Connect Biopharma Holdings Ltd (CNTB)
↓ Download CSV- Sector Manufacturing
- Incorporated E9
- Fiscal year ends Dec 31
In fiscal 2025, Connect Biopharma Holdings Ltd reported revenue of $64.0K, down 99.8% from the prior year. The company ran a net loss, with a net margin of -86687.5%. It held $56.08M in total assets against $14.10M in total liabilities.
Key ratios (FY2025)
-90740.6%
Operating margin
-86687.5%
Net margin
-132.2%
Return on equity
-99.8%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $64.0K | $26.03M | $0 | — |
| Operating Income | -$58.07M | -$22.45M | -$69.06M | — |
| Net Income | -$55.48M | -$15.63M | -$62.11M | — |
| EPS (Diluted) | $-1.00 | $-0.28 | $-1.13 | — |
| Total Assets | $56.08M | $101.28M | $127.38M | — |
| Total Liabilities | $14.10M | $9.12M | $25.88M | — |
| Shareholders' Equity | $41.98M | $92.17M | $101.50M | $158.42M |
| Cash & Equivalents | $38.34M | $78.23M | $105.66M | — |
| Operating Cash Flow | -$51.21M | -$23.61M | -$47.74M | — |
| Capital Expenditures | $434.0K | $750.0K | $81.0K | — |
| Shares Outstanding | 56.44M | 55.35M | 55.10M | — |